Prescription drug coverage and drug utilization

New evidence from the HRS prescription drug study

Research output: Contribution to journalArticle

Abstract

The linking of detailed information on health, medical care, and insurance to economic outcomes is a central feature of data collection efforts in the economics of aging. In this paper, I use newly available linked panel data from a unique supplement to the Health and Retirement Study (HRS) known as the Prescription Drug Study (PDS) to examine the impact of insurance coverage on prescription drug utilization for those 65 and older. Fixed-effect estimates suggest that gaining coverage resulted in a 15% increase in utilization. Gaining coverage also was associated with a 20-50% reduction in the incidence of cost-related non-adherence. However, even among the uninsured, only a relatively small proportion of drugs (12%) were associated with episodes of cost-related non-adherence.

Original languageEnglish (US)
Pages (from-to)49-65
Number of pages17
JournalJournal of Economic and Social Measurement
Volume41
Issue number1
DOIs
StatePublished - Apr 1 2016

Fingerprint

retirement
medication
coverage
utilization
drug
health
evidence
insurance coverage
costs
medical care
insurance
supplement
economics
incidence

Keywords

  • panel data
  • Prescription drugs
  • utilization

ASJC Scopus subject areas

  • Social Sciences(all)

Cite this

@article{7fdfb8ada8ee46b5aab6f37bf4ea8278,
title = "Prescription drug coverage and drug utilization: New evidence from the HRS prescription drug study",
abstract = "The linking of detailed information on health, medical care, and insurance to economic outcomes is a central feature of data collection efforts in the economics of aging. In this paper, I use newly available linked panel data from a unique supplement to the Health and Retirement Study (HRS) known as the Prescription Drug Study (PDS) to examine the impact of insurance coverage on prescription drug utilization for those 65 and older. Fixed-effect estimates suggest that gaining coverage resulted in a 15{\%} increase in utilization. Gaining coverage also was associated with a 20-50{\%} reduction in the incidence of cost-related non-adherence. However, even among the uninsured, only a relatively small proportion of drugs (12{\%}) were associated with episodes of cost-related non-adherence.",
keywords = "panel data, Prescription drugs, utilization",
author = "Gary Engelhardt",
year = "2016",
month = "4",
day = "1",
doi = "10.3233/JEM-150418",
language = "English (US)",
volume = "41",
pages = "49--65",
journal = "Journal of Economic and Social Measurement",
issn = "0747-9662",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Prescription drug coverage and drug utilization

T2 - New evidence from the HRS prescription drug study

AU - Engelhardt, Gary

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The linking of detailed information on health, medical care, and insurance to economic outcomes is a central feature of data collection efforts in the economics of aging. In this paper, I use newly available linked panel data from a unique supplement to the Health and Retirement Study (HRS) known as the Prescription Drug Study (PDS) to examine the impact of insurance coverage on prescription drug utilization for those 65 and older. Fixed-effect estimates suggest that gaining coverage resulted in a 15% increase in utilization. Gaining coverage also was associated with a 20-50% reduction in the incidence of cost-related non-adherence. However, even among the uninsured, only a relatively small proportion of drugs (12%) were associated with episodes of cost-related non-adherence.

AB - The linking of detailed information on health, medical care, and insurance to economic outcomes is a central feature of data collection efforts in the economics of aging. In this paper, I use newly available linked panel data from a unique supplement to the Health and Retirement Study (HRS) known as the Prescription Drug Study (PDS) to examine the impact of insurance coverage on prescription drug utilization for those 65 and older. Fixed-effect estimates suggest that gaining coverage resulted in a 15% increase in utilization. Gaining coverage also was associated with a 20-50% reduction in the incidence of cost-related non-adherence. However, even among the uninsured, only a relatively small proportion of drugs (12%) were associated with episodes of cost-related non-adherence.

KW - panel data

KW - Prescription drugs

KW - utilization

UR - http://www.scopus.com/inward/record.url?scp=84964528869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964528869&partnerID=8YFLogxK

U2 - 10.3233/JEM-150418

DO - 10.3233/JEM-150418

M3 - Article

VL - 41

SP - 49

EP - 65

JO - Journal of Economic and Social Measurement

JF - Journal of Economic and Social Measurement

SN - 0747-9662

IS - 1

ER -